Pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome: a critical appraisal
- PMID: 22212057
- DOI: 10.1111/j.1365-2133.2011.10754.x
Pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome: a critical appraisal
Comment in
-
Commentary: pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome.Br J Dermatol. 2012 Jan;166(1):14-5. doi: 10.1111/j.1365-2133.2011.10761.x. Br J Dermatol. 2012. PMID: 22212060 No abstract available.
Comment on
-
Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.N Engl J Med. 2011 Mar 24;364(12):1126-33. doi: 10.1056/NEJMoa1009717. N Engl J Med. 2011. PMID: 21428768
-
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.N Engl J Med. 2011 Mar 24;364(12):1134-43. doi: 10.1056/NEJMoa1013297. N Engl J Med. 2011. PMID: 21428769 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources